Overview
Portfolio
More
Asymmetry VC
Asymmetry VC seeks to back transformative early‑stage startups that have the potential to create civilization‑level impact. They focus on founders tackling grand challenges across AI, health, cleantech, and space, aiming...
Portfolio
20+
Employees
10+
Founded
N/A
AUM
≈ $240.0M
Investment focus
Stages
Seed
Industries
Artificial IntelligenceClean TechnologyDigital HealthAerospace
Geographic scope
Global
Fund details
Funds
Fund I
Vintage 2021 • $105.0M
Fund II
Vintage 2025 • $137.0M
Sources
Asymmetry VC
Asymmetry VC seeks to back transformative early‑stage startups that have the potential to create civilization‑level impact. They focus on founders tackling grand challenges across AI, health, cleantech, and space, aiming to push humanity forward.
Portfolio
20+
Employees
10+
Founded
N/A
AUM
≈ $240.0M
Funds
Fund I · Vintage 2021 • $105.0M
Fund II · Vintage 2025 • $137.0M
Stages
Seed
Industries
Artificial IntelligenceClean TechnologyDigital HealthAerospace
Geographic scope
Global
Sources
Showing 15 of 15 matched portfolio companies
Atomic Alchemy develops the Versatile Isotope Production Reactor (VIPR®) and employs advanced recycling processes to produce high-value radioisotopes from used nuclear fuel. The company addresses the critical need for a reliable domestic supply of isotopes for medical, research, industrial, and defense applications.
Funding: $150.0K
Rough estimate of the amount of funding raised
Funding: $150.0K
Rough estimate of the amount of funding raised
BillionToOne utilizes proprietary Quantitative Counting Templates (QCTs™) to detect and quantify disease-related DNA fragments at single base-pair resolution from cell-free DNA. This technology enables precise prenatal screening for recessive conditions and aneuploidies, addressing the need for accurate risk assessment from a simple maternal blood draw.
Funding: $425.9M
Rough estimate of the amount of funding raised
Funding: $425.9M
Rough estimate of the amount of funding raised
BTQ develops post-quantum infrastructure that includes custom programming languages, cloud software, and dedicated hardware to secure mission-critical networks against threats posed by quantum computing. Their solutions provide compact post-quantum signature schemes and hardware acceleration to enhance digital security and ensure the integrity of data transactions.
20+
1K+Approximate amount of employees
Funding: $150.0K
Rough estimate of the amount of funding raised
Funding: $150.0K
Rough estimate of the amount of funding raised
Coreshell Technologies develops low-cost, high-performance silicon anodes made from 100% domestically sourced metallurgical silicon, which can store ten times more energy than traditional graphite. This technology addresses the high cost and scalability issues of synthetic silicon, providing a more economical solution for electric vehicle batteries and accelerating the transition to decarbonization.
Funding: $15.9M
Rough estimate of the amount of funding raised
Funding: $15.9M
Rough estimate of the amount of funding raised
CytoReason develops a cell-centered computational model that analyzes biological data to map disease mechanisms and treatment effects. This technology enables pharmaceutical companies to prioritize drug development and make data-driven decisions by providing insights into drug performance across diverse patient populations.
Funding: $80.0M
Rough estimate of the amount of funding raised
Funding: $80.0M
Rough estimate of the amount of funding raised
The startup operates a mental health and wellness clinic that utilizes patient profiles, genetic data, and brain-chemical balance assessments to tailor treatment plans. By integrating scientific research and symptom analysis, the clinic aims to enhance patient well-being and improve mental health outcomes.
Funding: $81.0M
Rough estimate of the amount of funding raised
Funding: $81.0M
Rough estimate of the amount of funding raised
Genecis Bioindustries utilizes biotechnology to convert organic waste into polyhydroxyalkanoates (PHAs), a sustainable alternative to traditional plastics. This process addresses the environmental impact of single-use plastics by providing biodegradable materials suitable for various applications, including packaging, automotive parts, and medical products.
InpharmD™ provides a platform for clinical pharmacists to submit specific medical inquiries, enabling a tailored literature search that delivers curated, evidence-based responses. This service significantly reduces the time spent on research, allowing healthcare professionals to focus more on patient care, with a reported 85,850 clinical pharmacist hours saved.
Funding: $6.6M
Rough estimate of the amount of funding raised
Funding: $6.6M
Rough estimate of the amount of funding raised
Kernalbio develops mRNA therapies that enable selective translation of therapeutic proteins in target cells, utilizing a clinically validated delivery system to enhance tissue specificity. This approach addresses the limitations of traditional mRNA design, which often fails to effectively target specific cells within tissue and tumor microenvironments.
Funding: $25.0M
Rough estimate of the amount of funding raised
Funding: $25.0M
Rough estimate of the amount of funding raised
This startup provides vertically integrated reforestation services that include seed collection, seedling cultivation, site preparation, planting, and ongoing monitoring. By enabling landowners to restore wildfire-damaged forests at no cost through financing with carbon removal credits, the company directly addresses the urgent need for scalable solutions to mitigate climate change.
Funding: $58.9M
Rough estimate of the amount of funding raised
Funding: $58.9M
Rough estimate of the amount of funding raised
New Culture utilizes traditional cheesemaking techniques combined with modern fermentation technology to produce animal-free mozzarella that mimics the taste and texture of conventional cheese. This process eliminates lactose, cholesterol, hormones, and antibiotics while significantly reducing resource consumption, making it a sustainable alternative in the dairy industry.
Funding: $30.2M
Rough estimate of the amount of funding raised
Funding: $30.2M
Rough estimate of the amount of funding raised
Orbit Fab provides in-space refueling services through its RAFTI™ interface and fuel delivery shuttles, enabling satellites to refuel in orbit. This capability addresses the challenge of limited satellite operational lifespan by allowing for extended missions and enhanced maneuverability.
Funding: $45.9M
Rough estimate of the amount of funding raised
Funding: $45.9M
Rough estimate of the amount of funding raised
Rejuvenation Technologies utilizes nucleoside-modified TERT mRNA to temporarily activate telomerase, enabling the safe extension of telomeres in human cells. This approach addresses the critical shortening of telomeres, which contributes to cellular aging and various age-related diseases, by potentially reversing the effects of aging at the chromosomal level.
Funding: $15.2M
Rough estimate of the amount of funding raised
Funding: $15.2M
Rough estimate of the amount of funding raised
Statiq operates a network of over 7,000 electric vehicle charging stations across India, providing a mobile app that enables users to locate, book, and pay for charging sessions. The platform addresses the challenge of limited charging infrastructure by enhancing accessibility and convenience for electric vehicle owners.
Funding: $28.2M
Rough estimate of the amount of funding raised
Funding: $28.2M
Rough estimate of the amount of funding raised
Turion Space develops integrated hardware and software solutions for space infrastructure management and operations. They offer a unified software layer for fleet command, simulation, and data archiving for satellite operations. The company also provides configurable satellite platforms and advanced gridded ion propulsion systems to enhance in-orbit maneuverability and mission capability delivery.
Funding: $27.8M
Rough estimate of the amount of funding raised
Funding: $27.8M
Rough estimate of the amount of funding raised
Showing 5 of 5 unmatched portfolio companies